In response to the article entitled, "Get vaccine to those who need it most," I believe that the urgency for the vaccine expressed by the media poses a threat to consumers.

The H1N1 vaccine is considered experimental and could have unknown side effects. Health officials are even saying that there is a link between the vaccination and the lethal nerve disorder, Guillain-Barre Syndrome.

Although the virus presents a great risk to millions of lives, the vaccination's safety should be in question, and therefore, this form of prevention is not worth the risks it entails. Because the swine flu is curable and short-lasting, I believe that a better course of action would simply be to contract the disease and build up natural immunities to it.

The article said that "We urge all suburban counties to distribute the limited supply (of the vaccination) in this manner," meaning to pregnant women, young children and those with chronic health problems. However, the vaccine contains toxic ingredients, including MSG and mercury, which would be most harmful to these types of people.

The pharmaceutical industry is making a major profit off this virus, and I can't help but to question their intentions with these promotions for a risky drug. I feel that before the population goes to get vaccinated, they should first look into the negative effects this drug can have on its users.

Cheney Hagerup

Glen Ellyn